All News
Long-Term Prognosis in Children with Kawasaki Disease: Dr. David Liew ( @drdavidliew) #ACR20
https://t.co/Hg8nYWcD3V https://t.co/pJIGNMnRss
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @TheLancetRheum: Results of the NOVESA phase 2 trial of Ziritaxestat in patients with diffuse cutaneous #SSc presented by @sclerodermaUM at #ACR20
Improvements in mRSS and ACR-CRISS with Ziritaxestat, but not in lung outcomes. https://t.co/GCZj64i86c https://t.co/Pd6qGEGOev
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @MGHrheumatology : Congratulations to House of DMARDs, our new @ACRheum 2020 Knowledge Bowl Champions!! 🏆 We are so proud!! @kmdsilvaMD @JonathanDauMD @NasrallahMazen #ACR20 https://t.co/wvKvCDO1m4 https://t.co/wCGG2lIqAr
Links:
Dr. John Cush RheumNow ( View Tweet)
PROs in Psoriatic Arthritis: Dr. Antoni Chan ( @synovialjoints) reviews abstract #0169 presented at #ACR20.
https://t.co/hTlrZMNnab https://t.co/HMOMnT36zf
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @Janetbirdope : Gout has more comorbidities than RA & PsA #1466 Half of respondents are correct @RheumNow @CRASCRRheum #ACR20 https://t.co/T81eo3CGjq
Links:
Dr. John Cush RheumNow ( View Tweet)
Check this out!
Can PT-CDAI in Telemedicine be Used for Care in RA? Dr. Eric Dein ( @ejdein1) #ACR20
https://t.co/dAgYOFMMJC https://t.co/QV02h171yP
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @doctorRBC : Gender disparity in Ankylosing Spondylitis symptoms.
1⃣Women ⬆️Achilles tendonitis, plantar fasciitis, joint swelling, BASDAI>40, DMARD use
2⃣HLA-B not associated w/ enthesitis
@RheumNow #ACR20 Abs#1872 https://t.co/pBcpuqgq0K https://t.co/YWKFUdIgMl
Links:
Dr. John Cush RheumNow ( View Tweet)
"Erosions on X-ray: can we delegate this to the computers?" by Dr. David Liew ( @drdavidliew) #ACR20
https://t.co/YvKjAWebT9 https://t.co/RS4P29UVym
Links:
Dr. John Cush RheumNow ( View Tweet)
Rheumatoid Arthritis and ILD: Dr. Janet Pope ( @Janetbirdope) interviews Dr. Jeffrey Sparks ( @jeffsparks) about abstracts #0392, #0491, #1198 and #0489 presented at #ACR20.
https://t.co/e6HI1SqqSf https://t.co/naXAo8nc1g
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @uptoTate : What a great interview with @IreneBlancoMD regarding equity and inclusion in rheumatology. She is amazing! Such an important topic for all of us! #ACR20 @rheumnow https://t.co/HCnTD8XkAd
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Mrinalini Dey ( @DrMiniDey) interviews Dr. James Galloway on infection in rheumatic diseases, and the studies and presentations he's interested in on infection at #ACR20.
https://t.co/5HE7ByhjXo https://t.co/77oLtO2MEQ
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACRO20Tweets
"RT @RHEUMarampa : Large cohort of older RA pts newly rx w/HCQ or MTX:
👉~2-fold ⬆ risk of VTE – both PE and DVT- among patients newly treated with MTX vs. HCQ.
@RheumNow #ACR20 abs#2000 @DanielHSolomon https://t.co/4gK7hwdhIr" https://t.co/JsGBFrp7Hl
Links:
Dr. John Cush RheumNow ( View Tweet)
Did you know we have podcast? Search Rheum Now on Apple/Android/Soundcloud or listen directly through the link below.
https://t.co/wjBWCrKL34 https://t.co/Sin6gVXbeB
Links:
Dr. John Cush RheumNow ( View Tweet)
Miss anything during #ACR20? The RheumNow podcast has got it covered.
Catch our podcast on ACR20-Opening Day.
https://t.co/dG2H80Qycw https://t.co/EzNl4lm1fB
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @ejdein1 : #ACR20 Abs#L11. Efficacy of TOFA vs PBO in AS. At week 16, %ASAS20 responders 56% v 29% PBO; %ASAS40 40% vs 12%. @RheumNow #ACRBest https://t.co/knduk3l6xV https://t.co/SNommxn1jA
Links:
Dr. John Cush RheumNow ( View Tweet)
SKIPPAIN Trial: Dr. Sheila Reyes ( @RHEUMarampa) reviews abstract #0899 presented at #ACR20.
https://t.co/yoQ8MEH2Br https://t.co/1uRKEp88le
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @ejdein1 : Worth checking out the #ACR20 image competition. Here's an image of cerebral toxoplasmosis during ADA treatment for RA https://t.co/JH07pMjvRe https://t.co/H9LHwiw4xL
Links:
Dr. John Cush RheumNow ( View Tweet)
Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952 presented at #ACR20.
https://t.co/xeiMYLZEQa https://t.co/a4RJ6BrNgn
Links:
Dr. John Cush RheumNow ( View Tweet)
Vaccination with Shingrix: Does it work for patients on JAKi? #ACR20
https://t.co/PLWn3SshcI https://t.co/APBcfP1zlH
Links:
Dr. John Cush RheumNow ( View Tweet)
Nomenclature, Uveitis and Other Spondyloarthritis Features with Dr. Lianne Gensler #ACR20
https://t.co/zql7iySXOA https://t.co/PY9k108QTc
Links:
Dr. John Cush RheumNow ( View Tweet)
